Phibro Animal Health (NASDAQ:PAHC) Hits New 12-Month High at $17.42

Phibro Animal Health Co. (NASDAQ:PAHC) shares reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $17.42 and last traded at $17.36, with a volume of 47998 shares. The stock had previously closed at $16.77.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th.

Phibro Animal Health Trading Up 2.4 %

The company has a market cap of $695.79 million, a P/E ratio of 46.58, a PEG ratio of 6.30 and a beta of 0.63. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. The stock’s 50 day moving average is $13.39 and its 200-day moving average is $12.00.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The firm had revenue of $249.90 million for the quarter, compared to analysts’ expectations of $242.91 million. Research analysts anticipate that Phibro Animal Health Co. will post 1.12 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Brandes Investment Partners LP raised its stake in Phibro Animal Health by 38.5% during the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock valued at $23,922,000 after buying an additional 520,697 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Phibro Animal Health by 165.9% in the fourth quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after acquiring an additional 102,793 shares during the period. GSA Capital Partners LLP boosted its position in Phibro Animal Health by 227.0% in the third quarter. GSA Capital Partners LLP now owns 81,647 shares of the company’s stock worth $1,043,000 after purchasing an additional 56,676 shares during the last quarter. BNP Paribas Financial Markets increased its position in shares of Phibro Animal Health by 290.2% during the 4th quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock valued at $849,000 after purchasing an additional 54,506 shares during the last quarter. Finally, Brandywine Global Investment Management LLC lifted its stake in shares of Phibro Animal Health by 21.1% in the 3rd quarter. Brandywine Global Investment Management LLC now owns 257,200 shares of the company’s stock worth $3,284,000 after purchasing an additional 44,900 shares during the period. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.